Page last updated: 2024-11-12
neoruscogenin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 9910474 |
| MeSH ID | M0059481 |
Synonyms (21)
| Synonym |
|---|
| 17676-33-4 |
| neoruscogenin |
| LMST01080048 |
| delta5-convallamarogenin |
| spirosta-5,25(27)-dien-1beta,3beta-diol |
| d4e4kc2tuk , |
| einecs 241-660-1 |
| unii-d4e4kc2tuk |
| spirosta-5,25(27)-diene-1beta,3beta-diol |
| 25(27)-dehydroruscogenin |
| S2654 |
| spirosta-5,25(27)-diene-1,3-diol, (1b,3b)- |
| mfcd00210534 |
| spirosta-5,25(27)-diene-1,3-diol, (1.beta.,3.beta.)- |
| neoruscogenin [inci] |
| HY-N2253 |
| (1s,2s,4s,6r,7s,8r,9s,12s,13r,14r,16r)-7,9,13-trimethyl-5'-methylidenespiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-14,16-diol |
| spirosta-5,25(27)-diene-1,3-diol, (1beta,3beta)- |
| CS-0019582 |
| MS-27595 |
| AC-34907 |
Research Excerpts
Overview
Neoruscogenin is a plant-origin sapogenin that has the potential to modulate muscle growth. It was previously predicted by artificial intelligence to target myostatin (MSTN)
| Excerpt | Reference | Relevance |
|---|---|---|
| "Neoruscogenin is a plant-origin sapogenin that has the potential to modulate muscle growth among the small-molecule compounds that we previously predicted by artificial intelligence to target myostatin (MSTN). " | ( Novel Pro-myogenic Factor Neoruscogenin Induces Muscle Fiber Hypertrophy by Inhibiting MSTN Maturation and Activating the Akt/mTOR Pathway. Chen, J; Li, C; Li, H; Li, W; Liu, H; Ma, X; Tao, J; Zhang, D; Zhang, X, 2023) | 2.65 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 27.39
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.39) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (16.67%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||